350 related articles for article (PubMed ID: 23472659)
21. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
22. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.
Hsieh AC; Ruggero D
Clin Cancer Res; 2010 Oct; 16(20):4914-20. PubMed ID: 20702611
[TBL] [Abstract][Full Text] [Related]
23. Targeting the oncogene eIF4E in cancer: From the bench to clinical trials.
Borden KL
Clin Invest Med; 2011 Dec; 34(6):E315. PubMed ID: 22129918
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
[TBL] [Abstract][Full Text] [Related]
25. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
26. Ribavirin targets eIF4E dependent Akt survival signaling.
Tan K; Culjkovic B; Amri A; Borden KL
Biochem Biophys Res Commun; 2008 Oct; 375(3):341-5. PubMed ID: 18706892
[TBL] [Abstract][Full Text] [Related]
27. eIF4E activity is regulated at multiple levels.
Raught B; Gingras AC
Int J Biochem Cell Biol; 1999 Jan; 31(1):43-57. PubMed ID: 10216943
[TBL] [Abstract][Full Text] [Related]
28. eIF4E--from translation to transformation.
Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
[TBL] [Abstract][Full Text] [Related]
29. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity.
Coleman LJ; Peter MB; Teall TJ; Brannan RA; Hanby AM; Honarpisheh H; Shaaban AM; Smith L; Speirs V; Verghese ET; McElwaine JN; Hughes TA
Br J Cancer; 2009 May; 100(9):1393-9. PubMed ID: 19367274
[TBL] [Abstract][Full Text] [Related]
30. Tuning Specific Translation in Cancer Metastasis and Synaptic Memory: Control at the MNK-eIF4E Axis.
Bramham CR; Jensen KB; Proud CG
Trends Biochem Sci; 2016 Oct; 41(10):847-858. PubMed ID: 27527252
[TBL] [Abstract][Full Text] [Related]
31. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
32. Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.
Pettersson F; Yau C; Dobocan MC; Culjkovic-Kraljacic B; Retrouvey H; Puckett R; Flores LM; Krop IE; Rousseau C; Cocolakis E; Borden KL; Benz CC; Miller WH
Clin Cancer Res; 2011 May; 17(9):2874-84. PubMed ID: 21415224
[TBL] [Abstract][Full Text] [Related]
33. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
[TBL] [Abstract][Full Text] [Related]
35. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
Villalonga P; Fernández de Mattos S; Ridley AJ
J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
[TBL] [Abstract][Full Text] [Related]
36. Cap-binding protein 1-mediated and eukaryotic translation initiation factor 4E-mediated pioneer rounds of translation in yeast.
Gao Q; Das B; Sherman F; Maquat LE
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4258-63. PubMed ID: 15753296
[TBL] [Abstract][Full Text] [Related]
37. Targeting translation: eIF4E as an emerging anticancer drug target.
Lu C; Makala L; Wu D; Cai Y
Expert Rev Mol Med; 2016 Jan; 18():e2. PubMed ID: 26775675
[TBL] [Abstract][Full Text] [Related]
38. Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein.
Patrick RM; Lee JCH; Teetsel JRJ; Yang SH; Choy GS; Browning KS
J Biol Chem; 2018 Nov; 293(44):17240-17247. PubMed ID: 30213859
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
40. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling.
Sciascia Q; Pacheco D; McCoard SA
J Dairy Sci; 2013 Apr; 96(4):2327-2338. PubMed ID: 23462168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
